| Laura F Mcclure Barnes, MD | |
|
353 New Shackle Island Rd, Ste 204a, Hendersonville, TN 37075-2379 | |
| (615) 451-5481 | |
| Not Available |
| Full Name | Laura F Mcclure Barnes |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 24 Years |
| Location | 353 New Shackle Island Rd, Hendersonville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629094438 | NPI | - | NPPES |
| 4066719 | Other | BCBS OF TENNESSEE | |
| 7075475 | Other | AETNA | |
| 3640304 | Other | UNITED HEALTHCARE | |
| P00048449 | Other | RAILROAD MEDICARE | |
| 3887529 | Medicaid | TN | |
| 64070154 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 31609 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Hendersonville Medical Center | Hendersonville, TN | Hospital |
| Sumner Regional Medical Center | Gallatin, TN | Hospital |
| Tristar Skyline Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Oncology, Pllc | 4688586134 | 223 |
News Archive
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.
After a decade of research, Zapne LLC has released its signature acne treatment, Zapne, an all-natural product to treat acne without the harsh side effects of many current regimens. Zapne offers four key advantages over most acne treatments: The treatment system is formulated from natural, non-synthetic ingredients, produces no material side effects, requires only a single 15-minute weekly application, and produces visible results quickly, in some cases after only one or a few applications.
A weak heart is unable to pump an adequate amount of blood around the body. In Germany, this condition is now the commonest reason for patients to be admitted to hospital.
› Verified 6 days ago
| Entity Name | Tennessee Oncology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811955917 PECOS PAC ID: 4688586134 Enrollment ID: O20031103000534 |
News Archive
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.
After a decade of research, Zapne LLC has released its signature acne treatment, Zapne, an all-natural product to treat acne without the harsh side effects of many current regimens. Zapne offers four key advantages over most acne treatments: The treatment system is formulated from natural, non-synthetic ingredients, produces no material side effects, requires only a single 15-minute weekly application, and produces visible results quickly, in some cases after only one or a few applications.
A weak heart is unable to pump an adequate amount of blood around the body. In Germany, this condition is now the commonest reason for patients to be admitted to hospital.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura F Mcclure Barnes, MD Po Box 440100, Nashville, TN 37244-0100 Ph: (615) 329-0570 | Laura F Mcclure Barnes, MD 353 New Shackle Island Rd, Ste 204a, Hendersonville, TN 37075-2379 Ph: (615) 451-5481 |
News Archive
A genetic blue print that uncovers many of the mutations and genetic damage that drives prostate cancer and could lead to new treatments and better diagnosis has been found. This would mean earlier detection and new breeds of drugs to reverse the damage. Also each patient could have his own "cancer chart" made so that his treatment is personalized. The study, conducted by researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College, appears in the Feb. 10 issue of Nature.
An online training module designed for the evaluation and care of chronic pain greatly improved medical student clinical skills, according to a report in the Journal of the American Geriatrics Society.
After a decade of research, Zapne LLC has released its signature acne treatment, Zapne, an all-natural product to treat acne without the harsh side effects of many current regimens. Zapne offers four key advantages over most acne treatments: The treatment system is formulated from natural, non-synthetic ingredients, produces no material side effects, requires only a single 15-minute weekly application, and produces visible results quickly, in some cases after only one or a few applications.
A weak heart is unable to pump an adequate amount of blood around the body. In Germany, this condition is now the commonest reason for patients to be admitted to hospital.
› Verified 6 days ago
Dr. Disha Awasthi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 102 Wessington Pl, Hendersonville, TN 37075 Phone: 615-822-2214 Fax: 615-822-6519 | |
Mosunmola Adeshewa Adebowale Ademosu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 355 New Shackle Island Rd, Hendersonville, TN 37075 Phone: 615-338-1000 | |
Hailu T Kabtimer, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 919 W Main St M3, Hendersonville, TN 37075 Phone: 615-826-2102 Fax: 615-826-2743 | |
Mr. Scott Alan Hande, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 107 Glen Oak Blvd, Suite 202, Hendersonville, TN 37075 Phone: 615-826-0710 Fax: 615-826-0910 | |
Jung H. Lee, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 353 New Shackle Island Rd, #300c, Hendersonville, TN 37075 Phone: 615-338-3337 Fax: 615-338-3329 | |
Dr. Marshall R Johnson Jr., MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 355 New Shackle Island Rd, Hendersonville, TN 37075 Phone: 615-338-1000 Fax: 615-338-1101 | |
Paul S Daugherty, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 107 Imperial Blvd, Suite 5, Hendersonville, TN 37075 Phone: 615-826-3111 Fax: 615-826-3112 |